Employing capillary gas liquid chromatography thc levels of palmitic, palmitoleic, stearic, oleic, cis-vaccenic, linoleic, arachidonic and docosahexaenoic acids were measured in lung tissue and lung tumours from 28 patients undergoing surgery for bronchogenic carcinoma. There were significant increases in the majority of fatty acids in tumour tissue compared to normal tissue when the results were expressed in absolute units. However, when the relative changes in fatty acid concentration were studied, the most consistent findings were a significant rise in vaccenic acid and a fall in palmitic acid in tumour tissue compared to normal tissue. This change in the vaccenic: palmitic acid ratio may reflect specific changes in fatty acid metabolism in bronchogenic carcinoma tissue involving a A-9 desaturase.
Recently fatty acid measurements have been suggested to be useful in the diagnosis of cancer. 1, 2 The erythrocyte stearic: oleic acid ratio was suggested to be of use in the diagnosis of malignancy.l-' but more recent work has shown this parameter to be of no diagnostic use whatsoever. J5 However, fatty acid changes may occur in malignancies but only present in the actual tumour tissue itself and not be reflected in circulating erythrocytes. Such changes were reported in cervical carcinoma, with respect to the suggested free-radical product octadeca 9-cis-, II-trans-dienoic acid (ODA 9,11),6.7 although this work has recently been disproved." 10 The primary aim of this study was to investigate the fatty acid profiles in normal lung tissue and tumour tissue from the same patient and to establish whether any of the fatty acids investigated showed consistent changes. By comparing malignant and non-malignant tissue in the same patient, any changes due to dietary differences would be removed.
The work was done in conjunction with the measurement of ODA 9, I I in normal and malignant lung tissue. II This initial work compared fatty acid profiles in non-malignant lung tissue before and after clamping the pulmonary blood supply, and established that acute ischaemia did not significantly alter ODA 9, I III or any other Correspondence: Dr Nigel Lawson. fatty acid concentrations. 12 The fatty acid profiles from malignant and non-malignant tissue could therefore be compared directly without acute ischaemia affecting the results.
A previously described" capillary gas liquid chromatography method to measure fatty acid profiles in erythrocytes was adapted to determine the concentrations offatty acids in lung tissue and lung tumour.
Materials and methods
Unless otherwise stated, all reagents were obtained from the Sigma Chemical Company Ltd, Fancy Road, Poole, Dorset, UK.
PATIENT DETAILS
This study investigated 28 patients (24 men, 4 women; mean age 62 years, range 40-75 y) with bronchogenic carcinoma. Histologically the patients' tumours were classified as squamous cell carcinoma (20 patients), adenocarcinoma (4 patients), small cell carcinoma (I patient), bronchioalveolar carcinoma (I patient), malignant histiocytoma (I patient) and adenopapillary carcinoma (I patient). All patients had been admitted to hospital for curative resection.
PREPARATION OF SPECIMENS
Tissue samples were taken at the time of operation. From each patient a piece of normal lung tissue and a piece of tumour tissue were taken at the time of resection. Both tissue samples were immediately placed in liquid nitrogen and transferred to the laboratory where they were stored at -70'C until analysis. The effect of acute ischaemia, produced by restriction of the blood supply during the operation, had previously been shown to have no effect upon the fatty acid profiles."
Since this work was done in conjunction with the measurement of aDA 9, II by high performance liquid chromatography, and aDA 9, II is measured as a free acid, the homogenized specimens were treated with phospholipase A 2 in order to produce the free acid form. The initial report!' on fatty acid profiles in bronchogenic carcinoma tissue employed such hornogenates and phospholipase A 2 treatment was also performed on all subsequent specimens to enable consistent interpretation of results.
The two samples of tissue from each patient were analysed at the same time to remove potential between-batch variation. After thawing, aliquots of the tissues were weighed (200-1000 mg) and homogenized on ice in 10 mL of 0·1 mrnol/L Tris HCI buffer (pH 8, 9) containing I mol/L methanol and 500 lU/L phospholipase A 2 (from Naja naja venom, Sigma product P6139). Samples were homogenized in 25 mL plastic containers using a Polytron homogenizer, at a setting of6 for 30 s.
After homogeniza tion, samples were incubated at 25C for I h. After vigorous mixing, a 2 mL aliquot of the incubates was taken and used to determine the fatty acid profiles by gas liquid chromatography.
GAS LIQUIlJ CHROMATOGRAPHY STANDARDS
Fatty acid methyl ester standards were prepared from commercially available fatty acid methyl esters. Three different standard mixtures were employed.
Mixture one in hexane contained the following methyl esters: 1·97 gil palmitic acid, C16: 0; 2·77 gil palmitoleic acid, C16: I (9-cis); 3·96 gil stearic acid, C 18: 0; 3·83 gil elaidic acid, C 18: I (9-trans); 2·03 gil oleic acid, C 18: I (9-cis); 1·98 gil nonadeeanoic acid, C 19: 0; 2·0 I gil linoleic acid, C 18: 2 (9-, 12-eis); 2·0 gil arachidic acid, C20:0; 2·03 gil alpha-linolenic acid, C18:3 (9-, 12-, 15-cis); 2·01 gil heneicosanoic acid, C21 :0; 2·00 gil behenic acid, C22:0; and 5·00 gil arachidonic acid C20:4 (5-,8-, 11-, 14-cis).
Mixture two, in hexane, contained the following methyl esters: 2·5 gil palmitelaidic acid C 16: I (9-trans); 2·60 gil petrosclenic acid, C18: I (6-cis); 2·4 gil trans-vaccenic acid, C18: I (Ll-trans); 2·35 gil cis-vaccenic acid, C18: 1(11cis); 2·09 gil linolelaidic acid, C 18: 2 (9-, 12trans); 2·62 gil gamma-linolenic acid, C 18: 3 (6-, 9-, 12-cis); I gil eicosadienoic acid, C20: 2 (11-, 14-cis); I gil eicosatrienoic acid, C20: 3 (8-, 11-, 14-cis); I gil arachidonic acid, C20:4 C (5-, 8-, 11-, 14-cis); I gil eicosapentaenoic acid C20: 5 (5-, 8-, 11-, 14-, 17-cis).
Mixture three, in hexane/methanol (6: I, by volume) contained the following methyl esters: 10 gil docosahexaenoic acid, C22: 6 (4-, 7-, 10-, 13-, 16-, 19-cis); and 2·5 gil nervonic acid, C24: I (15cis). All standard mixtures were stored in glass tubes, under nitrogen at -20'C in the dark.
These standard mixtures were used to determine the total fatty acid profiles. Aliquots (0'1 mL) of each standard mixture were placed into separate glass screw top tubes, evaporated to dryness at 40"C under nitrogen and 2 mL of water added. These standards were then treated identically to the 2 mL tissue homogenates. A fresh set of standards was set up with each batch of tissue homogenates analysed.
GAS LIQUID CHROMATOGRAPHY OF FATTY

ACID PROFILES
Fatty acid profiles of lung tissue homogenates were prepared by modifications of a previously described rnethod.!'
The tissue homogenates were prepared as follows: to 2 mL of tissue homogenate in a glass screw-topped tube was added 5 mL ofmethanol/6 rnol/L HCI (5: I, by volume) and 0·2 mL of methanol containing 20 gil butylated hydroxytoluene (BHT), an antioxidant and I gil margaric acid, the internal standard. The samples were then incubated at 90"C, under nitrogen for 4 h to transesterify all the fatty acids. After cooling, the fatty acid methyl esters were extracted into 8 mL of hexane, washed with a saturated NaCI solution, dried over anhydrous sodium sulphate, and evaporated to dryness under nitrogen. The samples were then resuspended in 0·2 mL hexane, placed in sealed, brown glass ampoules and stored at -20"C until analysis (within I week of preparation).
Samples were analysed by capillary gas liquid chromatography as previously described," but with the following temperature profile: 150-200"C (2"/min); 200-240"C (5''1min); hold at 240'C for 6 min. This gave a total run time of 45 min (including re-equilibration to start conditions), therefore saving 20 min per run without losing resolution in any of the peaks of interest.
The results were expressed in absolute units, as mg fatty acid per g wet weight tissue, or in rela- 
tive units, as a percentage of the total weight of fatty acids. Expressing the results in relative units lowers the variability in profiles between samples."
STATISTICAL ANALYSIS
The Wilcoxon signed-ranks test was used to determine statistical significance. 14
Results
FATTY ACID DETECTED
When investigating the total fatty acid profiles, sixteen long-chain fatty acids were identified from the tissue hornogenates ( Fig. IA and B ). It was decided to restrict the quantitative aspects of the study to the following fatty acids: palmitic, palmitoleic, stearic, oleic, cis-vacccnic, linoleic, arachidonic and decosahexaenoic. These fatty acids generally gave responses greater than 10°1., of the internal standard. Most of the other fatty acids identified gave responses whieh were less than 5% of the internal standard. Although these less abundant fatty acids were not quantitatively analysed, profiles from tumour and normal tissues were always compared visually to see if any obvious, large differences occurred. The within-and between-batch coefficients of variation (CVs) of the eight fatty acids investigated are shown in Table I . All the fatty acids investigated had within-and between-batch CVs of less than 10%, the CVs generally being higher at lower fatty acid concentrations. The intra-tissue variation in the absolute concentration of fatty acids was considerable ( Table 2 ). Expressing the results in relative units decreased the intra-tissue variation. However several fatty acids still showed CVs in excess of 10'1., (palmitoleic, vaccenic, arachidonic). This may partially be a reflection of the higher withinbatch CVs associated with some of the fatty acids of lower concentrations. However, the large intra-tissue variation means that changes in fatty acid concentration would have to be both substantial and very consistent to reach statistical significance.
Recoveries of the fatty acid methyl esters were between 93% and 112% ( Table 3 ).
PA TIENT RESULTS
There was a significant increase in the total amount of fatty acids measured in the tumour tissue compared to normal lung tissue (P<O'OI; Table 4 ). Significant increases in the following individual fatty acids were demonstrated in tumour tissue compared to normal lung when the results were expressed in absolute units; oleic, arachidonic and docosahexaenoic acids (P<0·025); stearic and linoleic acids (P<O·OI); and vaccenic acid (P < 0·005; Table 4 ).
When the results were expressed in relative units, the mean vaccenic acid concentration was more than twice as high in tumour tissue compared to normal lung (Table 4 ). By contrast, palmitic acid levels were significantly lower in the tumour tissue compared to normal lung ( Table   4 ).
The relative changes in vaceenic and palmitic acid were very consistent. In over 90% of the patients investigated the relative vaccenic acid level was higher in the tumour tissue compared to normal lung. Similarly in 90"1., of patients the relative palmitic acid concentration was lower in the tumour tissue compared to normal lung. When the palmitic and vaccenic acid results were expressed relatively there was considerable overlap between tumour tissue and normal lung ( Fig.  2A and B) . When the results were expressed as a vaccenic: palmitic acid ratio this overlap was reduced (Fig. 2C) . However, if the criteria for the detection of squamous cell carcinoma was a vaccenic: palmitic acid ratio greater than 15,0, the vaceenic:palmitic acid ratio would only have a sensitivity for the detection of squamous cell carcinoma of 85%.
Expressing the results as a vaccenic: palmitic acid ratio enhances the difference between normal lung tissue (mean ±SD vaceenic: palmitic acid ratio =8'24±2'97) and tumour tissue (21'93 ± 10'95). It is also apparent that the biggest differences in the vaccenic: palmitic acid ratio occur with the squamous cell carcinomas, with a greater than IO-fold difference seen in one patient.
Discussion
The most abundant fatty acids found in lung tissue were palmitic, palmitoleic, stearic, oleic, cis-vaccenic, linoleic, arachidonic and docosahcxaenoic acids (Fig. IA) .
The precision and recoveries of the chromatography were similar to those previously described,!' even though a shorter run time was employed. All the results in this paper were obtained by trans-esterification with methanolic HCl to produce the methyl esters of the fatty acids. A second methylation step, involving boron trifluoride in methanol, to ensure complete methylation of all fatty acids," was omitted because it was found to be unnecessary.
The variation in fatty acids throughout a piece of tumour was large ( Table 2 ). It is possible that part of this variation could be due to the nonhomogeneity of tumour tissue involved. Varying degrees of necrosis, normal cellular regions and fibrosis may contribute to this variation.
The small (20 0 ft,), but significant, increase in the total fatty acid concentrations found in tumour tissue compared to normal tissue could be due to a number of factors. There could be increased de novo synthesis of fatty acids, decreased breakdown or loss to the circulation. A possible explanation could be a combination of several factors, where in the tumour tissue there is increased cell turnover and breakdown. This would lead to a local increase in the availability of fatty acids in the cell. Generally most tissues have a large capacity to synthesize glycerolipids, and these fatty acids may be converted into other glycerolipids, including triacylglycerol.
This general increase in the total fatty acid levels within the tumour tissue could explain why all eight specific fatty acids demonstrated a trend towards higher levels in the tumour tissue compared to normal lung (Table 4 ). If this general hypothesis were true, there should be no specific increases when the fatty acid profiles are expressed in relative units. However, only vaccenic was shown to be significantly increased when the results were expressed relatively. Furthermore, palmitic acid was shown to be decreased in tumour tissue compared to normal tissue when the results were expressed in relative units.
A previous preliminary study reported small but significant increases in the relative concentrations of stearic and docosahexaenoic acids in tumour tissue compared to normal lung." With the greater number of tissue samples these small differences were abolished (Table 4 ). However, the significant differences in the vaccenic and palmitic acids were verified.
It is unlikely that the process of metabolic compromise associated with the changes in stearic: oleic acid ratio seen in the erythrocytes of patients with cancer" and diabetes" can explain the results presented here. In the erythrocyte studies there was a decrease in cellular stearic acid, whereas in this study no such decrease in tissue stearic acid was observed.
Previous workers have reported increased levels of vaccenic acid in minimal deviation hepatoma 728C cells." rat hepatoma 17 and a variety of rat and mouse tumours. 1M This study provides the first evidence of such changes in lipid metabolism occurring in human tumours.
Vaccenic acid can be produced both anaerobically and aerobically. The anaerobic pathway only occurs in microorganisms. In mammals vaccine acid is produced firstly by~-9 desaturase activity upon palmitic acid in the mitochondria, to produce palmitoleic acid, followed by an elongation step in the endoplasmic reticulum. This is in contrast to the synthesis of oleic acid from palmitic acid, which involves firstly an elongation step to stearic acid, followed by the mitochondrial desaturation to oleic acid (Fig. 3) .
It is possible that this balance in the synthesis of oleic and vaccenic acids is altered in tumour tissue leading to more vaccenic acid being produced with a consequent drop in palmitic acid. Since there is no difference in the relative levels of oleic acid between the tumour and normal tissue, it appears that there may be a specific increase in thẽ -9 desaturase activity upon palmitic acid compared to stearic acid. Since no significant differences in the levels of palmitoleic acid (the direct precursor for vaccenic acid) were noted, it is possible that the elongation enzymes have sufficient capacity to convert all the extra palmitoleic acid directly to vaccenic acid. The difference in the vaccenic: palmitic acid ratio between lung cancer tissue and normal lung tissue may suggest a potential role for the ratio as a tumour marker. However, it is unlikely to be of use with serum measurements, because of the dilutional effect of the serum, and its potential use as an adjunct to cytology on bronchoscopic and sputum samples would be severely limited since its sensitivity in the detection of squamous cell carcinoma employing surgical samples was only 85'1." and the maximum difference between tumour and normal tissue was only IO-fold.
